45
Participants
Start Date
January 22, 2015
Primary Completion Date
June 30, 2019
Study Completion Date
June 30, 2019
Rituximab (Rituxan®)
2 Doses: 375 mg/m\^2 on Day 0 (within 12 hours of return to ICU following transplant) and Day 12 (+/-2 days).
Placebo
Placebo for Rituximab (Rituxan®). 2 Doses: 375 mg/m\^2 on Day 0 (within 12 hours of return to ICU following transplant) and Day 12 (+/-2 days).
Children's Hospital of Philadelphia, Philadelphia
Nationwide Children's Hospital, Columbus
Cincinnati Children's Hospital Medical Center, Cincinnati
Washington University, St Louis
Texas Children's Hospital, Houston
Stanford University, Palo Alto
Children's Hospital Boston, Boston
Clinical Trials in Organ Transplantation in Children
OTHER
Rho Federal Systems Division, Inc.
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH